The primary objective of this study is to evaluate the long-term safety of LDX administered
as a daily morning dose (30, 50, and 70 mg/day) in the treatment of adolescents (13-17 years
of age inclusive at the time of consent).
Minimum age: 13 Years.
Maximum age: 17 Years.
Gender(s): Both.
Clinical Study Centers, LLC, Little Rock, Arkansas 72205, United States
Valley Clinical Research, Inc., El Centro, California 92243, United States
Penninsula Research Associates, Inc., Rolling Hills Estates, California 90274, United States
Psychiatric Centers at San Diego (PCSD-Feighner Research Institute), San Diego, California 92108, United States
Elite Clinical Trials, Inc., Wildomar, California 92595, United States
Florida Clinical Research Center, LLC, Bradenton, Florida 34208, United States
Sarkis Clinical Trials, Gainsville, Florida 32607, United States
Amedica Research Institute, Inc., Hialeah, Florida 33013, United States
Clinical Neuroscience Solutions, Inc., Jacksonville, Florida 32216, United States
Clinical Neuroscience Solutions, Inc., Orlando, Florida 32806, United States
Miami Research Associates, South Miami, Florida 33143, United States
Janus Center for Psychiatric Research, West Palm Beach, Florida 33407, United States
Atlanta Center for Medical Research, Atlanta, Georgia 30308, United States
Northwest Behavioral Research Center, Marietta, Georgia 30060, United States
Capstone Clinical Research, Libertyville, Illinois 60048, United States
Clinco Inc., Terre Haute, Indiana 47802, United States
CIENTIFICA, Inc. at Prairie View, Newton, Kansas 67114, United States
Psychiatric Associates, Overland Park, Kansas 66211, United States
Vince and Associates Clinical Research, Inc., Overland Park, Kansas 66212, United States
Pedia Research LLC., Owensboro, Kentucky 42301, United States
Four Rivers Clinical Research, Inc., Paducah, Kentucky 42003, United States
Louisiana Research Associates, Inc., New Orleans, Louisiana 70114, United States
Bart Sangal, Troy, Michigan 48085, United States
Center for Psychiatry and Behavioral Medicine, Inc., Las vegas, Nevada 89128, United States
Children's Specialized Hospital, Toms River, New Jersey 08755, United States
Bioscience Research, LLC, Mount Kisco, New York 10549, United States
Triangle Neuropsychiatry, PLLC, Durham, North Carolina 27707, United States
Innovis Health/Odyssey Research, Fargo, North Dakota 58104, United States
University Hospitals of Cleveland Division of Child & Adolescent Psychiatry, Cleveland, Ohio 44106, United States
IPS Research Company, Oklahoma City, Oklahoma 73103, United States
OCCI, Eugene, Oregon 97401, United States
Summit Research Network, Portland, Oregon 97210, United States
OCCI, INC (Oregon Center for Clinical Investigations, Inc.), Salem, Oregon 97301, United States
CRI Worldwide, Philadelphia, Pennsylvania 19139, United States
Youth and Family Research Program/WPIC ADHD Research Program, Pittsburgh, Pennsylvania 15213, United States
CNS Healthcare, Memphis, Tennessee 38119, United States
Future Search Trials, Austin, Texas 78756, United States
Bayou City Research, Ltd., Houston, Texas 77007, United States
Red Oak Psychiatry Associates P.A., Houston, Texas 77090, United States
ADHD Clinic of San Antonio, San Antonio, Texas 78247, United States
Vermont Clinical Study Center, Burlington, Vermont 05401, United States
Neuropsychiatric Associates, Woodstock, Vermont 05091, United States
Neuroscience, Inc., Herndon, Virginia 20170, United States
Dominion Clinical Research, Midlothian, Virginia 23112, United States
Northwest Clinical Research Center, Bellevue, Washington 98004, United States